Integral Health Asset Management, LLC Arvinas, Inc. Transaction History

Integral Health Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $2.48 Million - $7.41 Million	175,000 New	175,000 $7.2 Million
Q2 2020 Aug 14, 2020	SELL	$29.88 - $56.74 $1.2 Million - $2.27 Million	-40,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$33.0 - $54.5 $1.32 Million - $2.18 Million	40,000 New	40,000 $1.61 Million

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.